A5003714894- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Genetic Neurodegenerative Diseases
- Cholinesterase and Neurodegenerative Diseases
- Neurological Disorders and Treatments
- Human Health and Disease
- Cyclopropane Reaction Mechanisms
- Folate and B Vitamins Research
- Healthcare Systems and Public Health
- Eicosanoids and Hypertension Pharmacology
- Functional Brain Connectivity Studies
- Botulinum Toxin and Related Neurological Disorders
- Neuroscience and Neuropharmacology Research
- Sleep and related disorders
- Alzheimer's disease research and treatments
- Blood groups and transfusion
- Dysphagia Assessment and Management
- Pharmacological Receptor Mechanisms and Effects
- Health Systems, Economic Evaluations, Quality of Life
- Neurological diseases and metabolism
- Amino Acid Enzymes and Metabolism
- Synthesis and pharmacology of benzodiazepine derivatives
- Dementia and Cognitive Impairment Research
Russian Medical Academy of Continuous Professional Education
2013-2021
Clinical Hospital No. 8
2021
The Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is a newly developed tool to assess disease (PD). Changes in scores on the scale over course of PD, including increasing duration and Hoehn Yahr (HY) stages, have not been described. objectives this study were analyze MDS-UPDRS Parts I through IV their differences based HY stage large cohort patients with PD. For cross-sectional study, demographic data collected, stage. Subscores analyzed using 1-way analyses...
To evaluate the validity of Russian version modified Addenbrooke's cognitive examination (ACE-m) for Alzheimer's disease (AD) diagnosis.ACE-m and MMSE, as a comparison scale, were administered to 78 patients including 49 with AD 29 healthy people.ACE-m demonstrated high in diagnosis dementia AD. Cronbach's alpha was 0.89. ACE-m is brief simple use test that measures wide spectrum functions, gives general impression about deficit diagnoses greater compared MMSE. This scale useful not only but...
Summary : Chronic fatigue is a persistent state of extreme weakness, exhaustion, loss strength (physical and/or mental), which occurs spontaneously or as result previous activity and makes it impossible to perform new activity. syndrome – condition with an unclearly defined status, the main manifestation rapid fatigue, persisting for at least several months, cannot be explained by another disease within specific disease, current physical exertion. It often referred somatoform disorders due...
Neuroacanthocytosis is a group of neurodegenerative diseases manifested by combition neurological symptoms (most often choreic hyperkinesis) and the presence an increased number acanthocytes (erythrocytes with horns) in peripheral blood. This includes chorea-acanthocytosis, MacLeod's syndrome, pantothenate kinase-associated neurodegeneration, Huntington-like disease type 2, some other very rare diseases. article presents genetically confirmed clinical case chorea-acanthocytosis associated...
Alzheimer Disease (AD) is a progressive neurodegenerative disorder characterized by loss of memory, difficulty in thinking, changes behavior and personality disorders. The risk developing epileptic seizures (ES) patients with AD increases significantly. Animal human studies have shown close relationship between the pathogenesis ES AD. exact prevalence remains unclear due to methodological difficulties, particular, detection cognitive impairment. EP types differ sporadic hereditary forms...